NCT01753531View on ClinicalTrials.gov

Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B

CompletedOBSERVATIONAL

Enrollment

677

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

June 30, 2013

Conditions

Influenza, Human

Interventions

DEVICE

Flu Symptoms

Trial Locations (3)

27103

Ardmore Family Practice, Winston-Salem

29412

Pharmacorp Clinical Trials, Inc., Charleston

78130

Hill Country Medical Associates, New Braunfels

All Listed Sponsors

lead

Sekisui Diagnostics, LLC

INDUSTRY

NCT01753531 - Clinical Performance Study of the Ultra Influenza A&B Test Using Nasal Swabs for Identifying Subjects Who Are Infected With the Influenza Virus Strain Type A or Type B | Biotech Hunter | Biotech Hunter